These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
328 related items for PubMed ID: 19675512
1. Weight gain associated with atypical and typical antipsychotics during treatment of adolescent schizophrenic psychoses: A retrospective study. Hrdlicka M, Zedkova I, Blatny M, Urbanek T. Neuro Endocrinol Lett; 2009; 30(2):256-61. PubMed ID: 19675512 [Abstract] [Full Text] [Related]
2. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies. Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J. Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596 [Abstract] [Full Text] [Related]
3. Onset of action of atypical and typical antipsychotics in the treatment of adolescent schizophrenic psychoses. Zedkova I, Dudova I, Urbanek T, Hrdlicka M. Neuro Endocrinol Lett; 2011 Dec; 32(5):667-70. PubMed ID: 22167144 [Abstract] [Full Text] [Related]
4. [Use of atypical antipsychotics in Charles Perrens psychiatric hospital (Bordeaux) analysis of prescribing practices for Amisulpride, Clozapine, Olanzapine and Risperidone]. Bret P, Bonnet F, Bret MC, Jaffré A. Encephale; 2002 Dec; 28(4):329-42. PubMed ID: 12232542 [Abstract] [Full Text] [Related]
5. Effects of second generation antipsychotics on leptin and ghrelin. Esen-Danaci A, Sarandöl A, Taneli F, Yurtsever F, Ozlen N. Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug 01; 32(6):1434-8. PubMed ID: 18579280 [Abstract] [Full Text] [Related]
6. The SNAP-25 gene may be associated with clinical response and weight gain in antipsychotic treatment of schizophrenia. Müller DJ, Klempan TA, De Luca V, Sicard T, Volavka J, Czobor P, Sheitman BB, Lindenmayer JP, Citrome L, McEvoy JP, Lieberman JA, Honer WG, Kennedy JL. Neurosci Lett; 2005 May 06; 379(2):81-9. PubMed ID: 15823421 [Abstract] [Full Text] [Related]
7. Correlations between weight changes and lipid profile changes in schizophrenic patients after antipsychotics therapy. Huang TL, Lu CY. Chang Gung Med J; 2007 May 06; 30(1):26-32. PubMed ID: 17477026 [Abstract] [Full Text] [Related]
8. Changes in neuroendocrine and metabolic hormones induced by atypical antipsychotics in normal-weight patients with schizophrenia. Popovic V, Doknic M, Maric N, Pekic S, Damjanovic A, Miljic D, Popovic S, Miljic N, Djurovic M, Jasovic-Gasic M, Dieguez C, Casanueva FF. Neuroendocrinology; 2007 May 06; 85(4):249-56. PubMed ID: 17570902 [Abstract] [Full Text] [Related]
9. Hospitalization risk associated with typical and atypical antipsychotic use in community-dwelling elderly patients. Aparasu RR, Jano E, Johnson ML, Chen H. Am J Geriatr Pharmacother; 2008 Oct 06; 6(4):198-204. PubMed ID: 19028375 [Abstract] [Full Text] [Related]
10. Sex difference in effects of typical and atypical antipsychotics on glucose-insulin homeostasis and lipid metabolism in first-episode schizophrenia. Wu RR, Zhao JP, Zhai JG, Guo XF, Guo WB. J Clin Psychopharmacol; 2007 Aug 06; 27(4):374-9. PubMed ID: 17632222 [Abstract] [Full Text] [Related]
11. Effectiveness and safety of antipsychotics in early onset psychoses: a long-term comparison. Cianchetti C, Ledda MG. Psychiatry Res; 2011 Oct 30; 189(3):349-56. PubMed ID: 21570128 [Abstract] [Full Text] [Related]
12. Weight change with atypical antipsychotics in the treatment of schizophrenia. Haddad P. J Psychopharmacol; 2005 Nov 30; 19(6 Suppl):16-27. PubMed ID: 16280334 [Abstract] [Full Text] [Related]
13. Formation of immature neutrophil leucocytes in schizophrenic patients treated with various antipsychotic drugs: comparisons and predictions. Delieu JM, Horobin RW, Duguid JK. J Psychopharmacol; 2006 Nov 30; 20(6):824-8. PubMed ID: 16401649 [Abstract] [Full Text] [Related]
14. Serum BDNF levels and weight gain in schizophrenic patients on long-term treatment with antipsychotics. Zhang XY, Tan YL, Zhou DF, Cao LY, Wu GY, Xu Q, Shen Y, Haile CN, Kosten TA, Kosten TR. J Psychiatr Res; 2007 Dec 30; 41(12):997-1004. PubMed ID: 17095017 [Abstract] [Full Text] [Related]
15. The implications of weight changes with antipsychotic treatment. Sussman N. J Clin Psychopharmacol; 2003 Jun 30; 23(3 Suppl 1):S21-6. PubMed ID: 12832946 [Abstract] [Full Text] [Related]
16. Clozapine: weight gain in a pair of monozygotic twins concordant for schizophrenia and mild mental retardation. Wehmeier PM, Gebhardt S, Schmidtke J, Remschmidt H, Hebebrand J, Theisen FM. Psychiatry Res; 2005 Feb 28; 133(2-3):273-6. PubMed ID: 15741002 [Abstract] [Full Text] [Related]
17. Weight changes during clozapine treatment. Briffa D, Meehan T. Aust N Z J Psychiatry; 1998 Oct 28; 32(5):718-21. PubMed ID: 9805596 [Abstract] [Full Text] [Related]
18. Risperidone associated weight, leptin, and anthropometric changes in children and adolescents with psychotic disorders in early treatment. Maayan LA, Vakhrusheva J. Hum Psychopharmacol; 2010 Mar 28; 25(2):133-8. PubMed ID: 20196182 [Abstract] [Full Text] [Related]
19. Antipsychotic-associated weight gain and clinical outcome parameters. Blin O, Micallef J. J Clin Psychiatry; 2001 Mar 28; 62 Suppl 7():11-21. PubMed ID: 11346191 [Abstract] [Full Text] [Related]
20. Association between the insulin-induced gene 2 (INSIG2) and weight gain in a German sample of antipsychotic-treated schizophrenic patients: perturbation of SREBP-controlled lipogenesis in drug-related metabolic adverse effects? Le Hellard S, Theisen FM, Haberhausen M, Raeder MB, Fernø J, Gebhardt S, Hinney A, Remschmidt H, Krieg JC, Mehler-Wex C, Nöthen MM, Hebebrand J, Steen VM. Mol Psychiatry; 2009 Mar 28; 14(3):308-17. PubMed ID: 18195716 [Abstract] [Full Text] [Related] Page: [Next] [New Search]